Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 279

1.

Characterisation of UHMWPE Polymer Powder for Laser Sintering.

Khalil Y, Hopkinson N, Kowalski A, Fairclough JPA.

Materials (Basel). 2019 Oct 25;12(21). pii: E3496. doi: 10.3390/ma12213496.

2.

Cost-effectiveness of Ambulatory Oxygen in improving quality of life in fibrotic lung disease: Preliminary evidence from the AmbOx Trial.

Whitty JA, Rankin J, Visca D, Tsipouri V, Mori L, Spencer L, Adamali H, Maher TM, Hopkinson NS, Birring SS, Farquhar M, Wells AU, Sestini P, Renzoni EA.

Eur Respir J. 2019 Nov 7. pii: 1901157. doi: 10.1183/13993003.01157-2019. [Epub ahead of print] No abstract available.

PMID:
31699838
3.

Patient experience of COPD care: outcomes from the British Lung Foundation Patient Passport.

Philip K, Gaduzo S, Rogers J, Laffan M, Hopkinson NS.

BMJ Open Respir Res. 2019 Oct 3;6(1):e000478. doi: 10.1136/bmjresp-2019-000478. eCollection 2019.

4.

Progression of physical inactivity in COPD patients: the effect of time and climate conditions - a multicenter prospective cohort study.

Boutou AK, Raste Y, Demeyer H, Troosters T, Polkey MI, Vogiatzis I, Louvaris Z, Rabinovich RA, van der Molen T, Garcia-Aymerich J, Hopkinson NS.

Int J Chron Obstruct Pulmon Dis. 2019 Sep 3;14:1979-1992. doi: 10.2147/COPD.S208826. eCollection 2019. Erratum in: Int J Chron Obstruct Pulmon Dis. 2019 Oct 18;14:2375.

5.

Lung Volume Reduction: Apex Treatments and the Ecology of Chronic Obstructive Pulmonary Disease Care.

Hopkinson NS.

Am J Respir Crit Care Med. 2019 Dec 1;200(11):1329-1331. doi: 10.1164/rccm.201908-1528ED. No abstract available.

6.

Environmental consequences of tobacco production and consumption.

Hopkinson NS, Arnott D, Voulvoulis N.

Lancet. 2019 Sep 21;394(10203):1007-1008. doi: 10.1016/S0140-6736(19)31888-4. No abstract available. Erratum in: Lancet. 2019 Oct 12;394(10206):1324.

PMID:
31544743
7.

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD.

Stolk J, Tov N, Chapman KR, Fernandez P, MacNee W, Hopkinson NS, Piitulainen E, Seersholm N, Vogelmeier CF, Bals R, McElvaney G, Stockley RA.

Eur Respir J. 2019 Nov 21;54(5). pii: 1900673. doi: 10.1183/13993003.00673-2019. Print 2019 Nov.

PMID:
31467115
8.

The lay health worker-patient relationship in promoting pulmonary rehabilitation (PR) in COPD: What makes it work?

Gilworth G, Lewin S, Wright AJ, Taylor SJ, Tuffnell R, Hogg L, Hopkinson NS, Singh SJ, White P.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119869329. doi: 10.1177/1479973119869329.

9.

A specific proteinase 3 activity footprint in α1-antitrypsin deficiency.

Newby PR, Crossley D, Crisford H, Stockley JA, Mumford RA, Carter RI, Bolton CE, Hopkinson NS, Mahadeva R, Steiner MC, Wilkinson TMA, Sapey E, Stockley RA.

ERJ Open Res. 2019 Aug 5;5(3). pii: 00095-2019. doi: 10.1183/23120541.00095-2019. eCollection 2019 Jul.

10.

Eligibility for Lung Volume Reduction Surgery in Patients With COPD Identified in a UK Primary Care Setting.

Whittaker HR, Connell O, Campbell J, Elbehairy AF, Hopkinson NS, Quint JK.

Chest. 2019 Aug 2. pii: S0012-3692(19)31391-1. doi: 10.1016/j.chest.2019.07.016. [Epub ahead of print]

PMID:
31381881
11.

Chronic obstructive pulmonary disease: diagnosis and management: summary of updated NICE guidance.

Hopkinson NS, Molyneux A, Pink J, Harrisingh MC; Guideline Committee (GC).

BMJ. 2019 Jul 29;366:l4486. doi: 10.1136/bmj.l4486. No abstract available.

12.

Music and dance in chronic lung disease.

Philip K, Lewis A, Hopkinson NS.

Breathe (Sheff). 2019 Jun;15(2):116-120. doi: 10.1183/20734735.0007-2019.

13.

Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey.

Stevens MJ, Walker-Bone K, Culliford DJ, Alcacer-Pitarch B, Blake A, Hopkinson N, Teh LS, Vital EM, Edwards CJ, Williams AE, Cherry L.

J Foot Ankle Res. 2019 Apr 29;12:26. doi: 10.1186/s13047-019-0335-0. eCollection 2019.

14.

Climate change and lung health: presidential failure, professional responsibility.

Hopkinson NS, Hart N, Jenkins G, Rosenfeld M, Smyth AR, Wilkinson AJK, Kaminski N.

Thorax. 2019 Jul;74(7):627-628. doi: 10.1136/thoraxjnl-2019-213184. Epub 2019 Apr 21. No abstract available.

15.

Patterns of breathlessness and associated consulting behaviour: results of an online survey.

Elbehairy AF, Quint JK, Rogers J, Laffan M, Polkey MI, Hopkinson NS.

Thorax. 2019 Aug;74(8):814-817. doi: 10.1136/thoraxjnl-2018-212950. Epub 2019 Apr 8.

16.

Keep out of reach of children-the case for increasing the legal age for tobacco purchase to 21.

Hopkinson NS.

BMJ. 2019 Mar 27;364:l1330. doi: 10.1136/bmj.l1330. No abstract available.

17.

Improving uptake and completion of pulmonary rehabilitation in COPD with lay health workers: feasibility of a clinical trial.

White P, Gilworth G, Lewin S, Hogg L, Tuffnell R, Taylor SJC, Hopkinson NS, Hart N, Singh SJ, Wright AJ.

Int J Chron Obstruct Pulmon Dis. 2019 Mar 12;14:631-643. doi: 10.2147/COPD.S188731. eCollection 2019.

18.

Our patients and our planet-holistic considerations for inhaler choice.

Wilkinson A, Hillman T, Hopkinson NS, Janson C, Smith J, Woodcock AA.

Lancet Respir Med. 2019 Mar;7(3):e11. doi: 10.1016/S2213-2600(19)30035-9. No abstract available.

19.

The prominence of e-cigarettes is a symptom of decades of failure to tackle smoking properly.

Hopkinson NS.

BMJ. 2019 Feb 14;364:l647. doi: 10.1136/bmj.l647. No abstract available.

20.

Pulmonary rehabilitation in patients with mustard gas lung disease: a study protocol for a randomized controlled trial.

Sedighi Moghadam MR, Ghanei M, Kenn K, Hopkinson NS.

Trials. 2019 Feb 14;20(1):132. doi: 10.1186/s13063-019-3180-3.

21.

Respiratory disease is in the long term plan.

Hopkinson N.

BMJ. 2019 Jan 30;364:l413. doi: 10.1136/bmj.l413. No abstract available.

22.

Smartphone-Based Physical Activity Telecoaching in Chronic Obstructive Pulmonary Disease: Mixed-Methods Study on Patient Experiences and Lessons for Implementation.

Loeckx M, Rabinovich RA, Demeyer H, Louvaris Z, Tanner R, Rubio N, Frei A, De Jong C, Gimeno-Santos E, Rodrigues FM, Buttery SC, Hopkinson NS, Büsching G, Strassmann A, Serra I, Vogiatzis I, Garcia-Aymerich J, Polkey MI, Troosters T.

JMIR Mhealth Uhealth. 2018 Dec 21;6(12):e200. doi: 10.2196/mhealth.9774.

23.

Open letter to Simon Stevens to ensure that tobacco dependence treatment is provided for every smoker cared for by the NHS, as part of the long term plan.

Goddard A, Burn W, Regan L, Viner R, Stokes-Lampard H, Mahajan R, Anagnostara E, Hollins S, Wessely S, Arnott D, Cramer S, Watson M, Black C, Ashcroft R, Hopkinson N; 800 doctors, health professionals, and academics.

BMJ. 2018 Nov 15;363:k4827. doi: 10.1136/bmj.k4827. No abstract available.

24.

Smoking uptake in UK children: analysis of the UK Millennium Cohort Study.

Laverty AA, Filippidis FT, Taylor-Robinson D, Millett C, Bush A, Hopkinson NS.

Thorax. 2019 Jun;74(6):607-610. doi: 10.1136/thoraxjnl-2018-212254. Epub 2018 Nov 15.

25.

CELEB trial: Comparative Effectiveness of Lung volume reduction surgery for Emphysema and Bronchoscopic lung volume reduction with valve placement: a protocol for a randomised controlled trial.

Buttery S, Kemp SV, Shah PL, Waller D, Jordan S, Lee JT, Banya W, Steiner MC, Hopkinson NS.

BMJ Open. 2018 Oct 17;8(10):e021368. doi: 10.1136/bmjopen-2017-021368.

26.

Tobacco smoke and environmental injustice.

Hopkinson NS.

BMJ. 2018 Oct 8;363:k4201. doi: 10.1136/bmj.k4201. No abstract available.

27.

Child awareness of and access to cigarettes: impacts of the point-of-sale display ban in England.

Laverty AA, Vamos EP, Millett C, Chang KC, Filippidis FT, Hopkinson NS.

Tob Control. 2019 Sep;28(5):526-531. doi: 10.1136/tobaccocontrol-2018-054511. Epub 2018 Sep 20.

28.

Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trial.

Visca D, Mori L, Tsipouri V, Fleming S, Firouzi A, Bonini M, Pavitt MJ, Alfieri V, Canu S, Bonifazi M, Boccabella C, De Lauretis A, Stock CJW, Saunders P, Montgomery A, Hogben C, Stockford A, Pittet M, Brown J, Chua F, George PM, Molyneaux PL, Margaritopoulos GA, Kokosi M, Kouranos V, Russell AM, Birring SS, Chetta A, Maher TM, Cullinan P, Hopkinson NS, Banya W, Whitty JA, Adamali H, Spencer LG, Farquhar M, Sestini P, Wells AU, Renzoni EA.

Lancet Respir Med. 2018 Oct;6(10):759-770. doi: 10.1016/S2213-2600(18)30289-3. Epub 2018 Aug 28.

29.

Cigarette Smoking: An Assessment of Tobacco's Global Environmental Footprint Across Its Entire Supply Chain.

Zafeiridou M, Hopkinson NS, Voulvoulis N.

Environ Sci Technol. 2018 Aug 7;52(15):8087-8094. doi: 10.1021/acs.est.8b01533. Epub 2018 Jul 23.

30.

Response.

Pereira M, Williams S, Restrick L, Cullinan P, Hopkinson NS.

Clin Med (Lond). 2018 Jun;18(3):268-269. doi: 10.7861/clinmedicine.18-3-268a. No abstract available.

31.

Exercise response to oxygen supplementation is not associated with survival in hypoxemic patients with obstructive lung disease.

Sadaka AS, Montgomery AJ, Mourad SM, Polkey MI, Hopkinson NS.

Int J Chron Obstruct Pulmon Dis. 2018 May 17;13:1607-1612. doi: 10.2147/COPD.S163119. eCollection 2018.

32.

Vascular inflammation and aortic stiffness: potential mechanisms of increased vascular risk in chronic obstructive pulmonary disease.

Fisk M, Cheriyan J, Mohan D, McEniery CM, Forman J, Cockcroft JR, Rudd JHF, Tal-Singer R, Hopkinson NS, Polkey MI, Wilkinson IB.

Respir Res. 2018 May 24;19(1):100. doi: 10.1186/s12931-018-0792-1.

33.

Singing for Lung Health: service evaluation of the British Lung Foundation programme.

Lewis A, Cave P, Hopkinson NS.

Perspect Public Health. 2018 Jul;138(4):215-222. doi: 10.1177/1757913918774079. Epub 2018 May 14.

34.

The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: A randomised double-blind placebo-controlled trial.

Fisk M, Cheriyan J, Mohan D, Forman J, Mäki-Petäjä KM, McEniery CM, Fuld J, Rudd JHF, Hopkinson NS, Lomas DA, Cockcroft JR, Tal-Singer R, Polkey MI, Wilkinson IB.

PLoS One. 2018 Mar 22;13(3):e0194197. doi: 10.1371/journal.pone.0194197. eCollection 2018.

35.

Barriers to influenza vaccination in healthcare workers.

Pereira M, Williams S, Restrick L, Cullinan P, Hopkinson NS.

BMJ. 2018 Mar 15;360:k1141. doi: 10.1136/bmj.k1141. No abstract available.

36.

Adult-onset Still's disease with prominent polyserositis.

Farooq Sheikh AS, Marks J, Hopkinson N.

Scott Med J. 2018 May;63(2):63-66. doi: 10.1177/0036933018760763. Epub 2018 Mar 5.

PMID:
29506437
37.

Endobronchial valves for emphysema: an individual patient-level reanalysis of randomised controlled trials.

Klooster K, Slebos DJ, Zoumot Z, Davey C, Shah PL, Hopkinson NS.

BMJ Open Respir Res. 2017 Nov 2;4(1):e000214. doi: 10.1136/bmjresp-2017-000214. eCollection 2017.

38.

Both moderate and severe exacerbations accelerate physical activity decline in COPD patients.

Demeyer H, Costilla-Frias M, Louvaris Z, Gimeno-Santos E, Tabberer M, Rabinovich RA, de Jong C, Polkey MI, Hopkinson NS, Karlsson N, Serra I, Vogiatzis I, Troosters T, Garcia-Aymerich J; PROactive Consortium.

Eur Respir J. 2018 Jan 25;51(1). pii: 1702110. doi: 10.1183/13993003.02110-2017. Print 2018 Jan. No abstract available.

39.

London ambulance source data on choking incidence for the calendar year 2016: an observational study.

Pavitt MJ, Nevett J, Swanton LL, Hind MD, Polkey MI, Green M, Hopkinson NS.

BMJ Open Respir Res. 2017 Dec 10;4(1):e000215. doi: 10.1136/bmjresp-2017-000215. eCollection 2017.

40.

Healthcare worker influenza vaccination and sickness absence - an ecological study.

Pereira M, Williams S, Restrick L, Cullinan P, Hopkinson NS; London Respiratory Network.

Clin Med (Lond). 2017 Dec;17(6):484-489. doi: 10.7861/clinmedicine.17-6-484.

41.

Redefining Cut-Points for High Symptom Burden of the Global Initiative for Chronic Obstructive Lung Disease Classification in 18,577 Patients With Chronic Obstructive Pulmonary Disease.

Smid DE, Franssen FME, Gonik M, Miravitlles M, Casanova C, Cosio BG, de Lucas-Ramos P, Marin JM, Martinez C, Mir I, Soriano JB, de Torres JP, Agusti A, Atalay NB, Billington J, Boutou AK, Brighenti-Zogg S, Chaplin E, Coster S, Dodd JW, Dürr S, Fernandez-Villar A, Groenen MTJ, Guimarães M, Hejduk K, Higgins V, Hopkinson NS, Horita N, Houben-Wilke S, Janssen DJA, Jehn M, Joerres R, Karch A, Kelly JL, Kim YI, Kimura H, Koblizek V, Kocks JH, Kon SSC, Kwon N, Ladeira I, Lee SD, Leuppi JD, Locantore N, Lopez-Campos JL, D-C Man W, Maricic L, Mendoza L, Miedinger D, Mihaltan F, Minami S, van der Molen T, Murrells TJ, Nakken N, Nishijima Y, Norman IJ, Novotna B, O'Donnell DE, Ogata Y, Pereira ED, Piercy J, Price D, Pothirat C, Raghavan N, Ringbaek T, Sajkov D, Sigari N, Singh S, Small M, da Silva GF, Tanner RJ, Tsiligianni IG, Tulek B, Tzanakis N, Vanfleteren LEGW, Watz H, Webb KA, Wouters EFM, Xie GG, Yoshikawa M, Spruit MA.

J Am Med Dir Assoc. 2017 Dec 1;18(12):1097.e11-1097.e24. doi: 10.1016/j.jamda.2017.09.003. Review.

42.

Lung Volume Reduction in Advanced Emphysema.

Hopkinson NS.

Tanaffos. 2017;16(Suppl 1):S9. No abstract available.

43.

Pulmonary Rehabilitation for COPD.

Hopkinson N.

Tanaffos. 2017;16(Suppl 1):S7-S8. No abstract available.

44.

Acute Schmorl's node: a forgotten cause of severe back pain.

Sheikh A, Hopkinson N.

Scand J Rheumatol. 2018 Sep;47(5):429-430. doi: 10.1080/03009742.2017.1369154. Epub 2017 Oct 31. No abstract available.

PMID:
29087233
45.

Adjuncts for sputum clearance in COPD: clinical consensus versus actual use.

Barker R, Laverty AA, Hopkinson NS.

BMJ Open Respir Res. 2017 Jul 29;4(1):e000226. doi: 10.1136/bmjresp-2017-000226. eCollection 2017.

46.

Singing for Lung Health: a qualitative assessment of a British Lung Foundation programme for group leaders.

Lewis A, Cave P, Hopkinson NS.

BMJ Open Respir Res. 2017 Jul 29;4(1):e000216. doi: 10.1136/bmjresp-2017-000216. eCollection 2017.

47.

Patient experience of lung volume reduction procedures for emphysema: a qualitative service improvement project.

Buttery S, Lewis A, Oey I, Hargrave J, Waller D, Steiner M, Shah PL, Kemp SV, Jordan S, Hopkinson NS.

ERJ Open Res. 2017 Aug 11;3(3). pii: 00031-2017. doi: 10.1183/23120541.00031-2017. eCollection 2017 Jul.

48.

Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years.

Buttery SC, Mohan D, Fisk M, Hopkinson NS, Tal-Singer R, Wilkinson IB, Polkey MI.

Eur Respir J. 2017 Aug 10;50(2). pii: 1700707. doi: 10.1183/13993003.00707-2017. Print 2017 Aug. No abstract available.

49.

Physical activity patterns and clusters in 1001 patients with COPD.

Mesquita R, Spina G, Pitta F, Donaire-Gonzalez D, Deering BM, Patel MS, Mitchell KE, Alison J, van Gestel AJ, Zogg S, Gagnon P, Abascal-Bolado B, Vagaggini B, Garcia-Aymerich J, Jenkins SC, Romme EA, Kon SS, Albert PS, Waschki B, Shrikrishna D, Singh SJ, Hopkinson NS, Miedinger D, Benzo RP, Maltais F, Paggiaro P, McKeough ZJ, Polkey MI, Hill K, Man WD, Clarenbach CF, Hernandes NA, Savi D, Wootton S, Furlanetto KC, Cindy Ng LW, Vaes AW, Jenkins C, Eastwood PR, Jarreta D, Kirsten A, Brooks D, Hillman DR, Sant'Anna T, Meijer K, Dürr S, Rutten EP, Kohler M, Probst VS, Tal-Singer R, Gil EG, den Brinker AC, Leuppi JD, Calverley PM, Smeenk FW, Costello RW, Gramm M, Goldstein R, Groenen MT, Magnussen H, Wouters EF, ZuWallack RL, Amft O, Watz H, Spruit MA.

Chron Respir Dis. 2017 Aug;14(3):256-269. doi: 10.1177/1479972316687207. Epub 2017 Feb 24.

50.

Putative Mechanisms of Action of Endobronchial Coils.

Palamidas AF, Kemp SV, Shen M, McNulty W, Zoumot Z, Hopkinson NS, Yang GZ, Shah PL.

Am J Respir Crit Care Med. 2017 Jul 1;196(1):109-115. doi: 10.1164/rccm.201606-1123LE. No abstract available.

Supplemental Content

Loading ...
Support Center